New inhaler aims to ease chemo mouth pain for cancer patients
NCT ID NCT07327216
First seen Jan 11, 2026 · Last updated May 13, 2026 · Updated 15 times
Summary
This study tests if a drug called Sapylin, given through an inhaler, can prevent or reduce painful mouth sores caused by chemotherapy and radiation in people with nasopharyngeal cancer. About 180 adults with advanced cancer will be randomly assigned to receive either Sapylin or a standard steroid treatment. The goal is to find a safer and more effective way to manage this common side effect and help patients complete their cancer therapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NASOPHARYNGEAL CARCINOMA (NPC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Affiliated Hospital of Guangdong Medical University
RECRUITINGZhanjiang, Guangdong, China
Conditions
Explore the condition pages connected to this study.